Tag Archives: AMLs

Episode 5: TSC Kidney Manifestations & Consensus Guidelines for Surveillance and Treatment



In episode 5 of TSC Now, Dan Klein talks to Dr. John Bissler, MD, Clinic Director of the Tuberous Sclerosis Complex Center of Excellence located at Le Bonheur Children’s Hospital, Director of Pediatric Nephrology at the University of Tennessee Health Science Center, and the Medical Director of Nephrology at St. Jude’s Children’s Hospital. They discuss common kidney manifestations of tuberous sclerosis complex (TSC), including renal cysts and renal angiomyolipoma (AML). The majority of individuals (greater than 80%) with TSC will develop some form of renal disease during their lifetime and renal-related disease is the most common cause of TSC-related death in adults, so they discuss the consensus guidelines for surveillance and treatment as it relates to kidney manifestations in TSC. They also discuss ongoing research to discover new treatments for AMLs and renal cysts.

To learn more about the kidney manifestations of TSC visit: https://www.tsalliance.org/about-tsc/signs-and-symptoms-of-tsc/kidneys/

To read about the general clinical consensus guidelines visit www.tsalliance.org/consensus. You can also read about the specific renal guidelines for TSC at: https://www.ncbi.nlm.nih.gov/pubmed/27504842.

Finally, to read Dr. Bissler’s paper on the reduction of post-embolization syndrome visit: https://www.ncbi.nlm.nih.gov/pubmed/11979340.